OncoGenex Pharmaceuticals Net Income Quarterly:
-6.697M for March 31, 2013OncoGenex Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -6.697M |
| Dec. 31, 2012 | -4.103M |
| Sept. 30, 2012 | -5.92M |
| June 30, 2012 | -4.215M |
| March 31, 2012 | -6.86M |
| Dec. 31, 2011 | -9.569M |
| Sept. 30, 2011 | 4.47M |
| June 30, 2011 | -6.53M |
| March 31, 2011 | -3.045M |
| Dec. 31, 2010 | -2.80M |
| Sept. 30, 2010 | -6.894M |
| June 30, 2010 | 0.154M |
| March 31, 2010 | -3.044M |
| Dec. 31, 2009 | 3.881M |
| Sept. 30, 2009 | -2.385M |
| June 30, 2009 | -4.563M |
| March 31, 2009 | -2.409M |
| Dec. 31, 2008 | -4.956M |
| Sept. 30, 2008 | 4.577M |
| June 30, 2008 | -3.807M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
OGXI Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | -1.139M |
| Merus Labs International | 0.2991M |
| China Biologic Products | 5.809M |
OGXI Net Income Quarterly Rankings
| Overall |
37th percentile 4724 of 7590 |
| Sector |
23rd percentile 498 of 651 in Healthcare |
| Industry |
37th percentile 148 of 238 in Biotechnology |
OGXI Net Income Quarterly Range, Past 5 Years
| Minimum | -9.569M | Dec 2011 |
| Maximum | 4.577M | Sep 2008 |
| Average | -3.236M |
